Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/1990
05/17/1990WO1990005142A1 Polypeptides
05/17/1990WO1990004979A2 Method of preventing or reducing eosinophilia
05/17/1990WO1990004978A1 Method of directing immune response to a viral binding site
05/17/1990WO1990002802A3 Viral nucleotide sequences
05/17/1990CA2003211A1 Monoclonal antibodies
05/16/1990EP0368819A1 Expression of the binding subunit of cholera toxin with the aid of foreign promoters and/or leader sequences
05/16/1990EP0368684A1 Cloning immunoglobulin variable domain sequences.
05/16/1990EP0368668A2 Antibody-drug conjugates
05/16/1990EP0368466A2 Compositions and methods for the treatment and prevention of gram-negative bacterial infections
05/16/1990EP0368222A1 Anti-fucosylceramide monoclonal antibody
05/16/1990EP0368131A2 Neoglucoproteins, their preparation and use
05/16/1990CA2003110A1 Monoclonal antibody specifically recognizing n-glycolyl type gm , hydridoma producing the antibody and method for preparing the hybridoma
05/16/1990CA2003042A1 Monoclonal antibody recognizing a reg protein
05/15/1990US4925792 Process for producing proteins correlated with the diphtheric toxin
05/15/1990US4925787 Monoclonal anti-idiotypic antibody, method for production thereof, and hybridoma producing said antibody
05/15/1990US4925784 Expression and purification of an HTLV-III gag/env gene protein
05/15/1990US4925662 Antitumor agent bonded to human immunoglobulin
05/15/1990US4925648 Two specific antibodies(or fragments) bound to imaging agents
05/15/1990CA1269041A1 Method for determining a ligand
05/14/1990CA2002869A1 Cloned genes which encode elam-1 and fusion proteins thereof, the protein products expressed therefrom, pharmaceutical compositions and the use thereof
05/14/1990CA2002860A1 Antibodies specific for elam-1 and the use thereof
05/10/1990CA2441636A1 Natural killer stimulatory factor
05/10/1990CA2000483A1 Antibody-drug conjugates
05/09/1990EP0367644A1 Nucleotide sequence codings for a protein with urea reactivity
05/09/1990EP0367641A2 Lymphokines, DNA sequences encoding these lymphokines and pharmaceutical compositions containing these lymphokines
05/09/1990EP0367596A1 Antagonist to interleukin-5 for preventing or reducing eosinophilia
05/09/1990EP0367306A2 Procedure for polymerized allergenis production
05/09/1990EP0367223A2 Chelants possessing ortho ligating functionality and complexes thereof
05/09/1990CA2002530A1 Anti-fucosylceramide monoclonal antibody
05/08/1990CA1268900A1 Immunomodulators obtained by hemisynthesis of a bacterial polysaccharide isolated from a mutant strain of klebsiella pneumoniae
05/08/1990CA1268707A1 Process for the virus-inactivation of immunoglobulin
05/03/1990WO1990004790A1 Method for detection of human papillomavirus (hpv) for diagnostic purposes
05/03/1990WO1990004641A1 FILAMENTOUS HEMAGGLUTININ OF $i(B. PERTUSSIS)
05/03/1990WO1990004637A1 NUCLEOTIDE SEQUENCES EXPRESSING THE ADENYL CYCLASE OF $i(B. ANTHRACIS)
05/03/1990WO1990004633A1 ACTIVATION AND GROWTH OF HUMAN TUMOR-INFILTRATING LYMPHOCYTES USING ANTIBODIES TO CD3 OR TcR
05/03/1990WO1990004417A1 Methods of and compositions for diagnosing, monitoring and treating the early stages of osteoarthritis
05/03/1990WO1990004415A1 Anti-idiotypic antibody induction of antitumor response
05/03/1990WO1990004413A1 ANTIBODY CONJUGATES WITH TWO OR MORE COVALENTLY LINKED Fc REGIONS
05/03/1990WO1990004412A1 Liposome immunoadjuvants containing il-2
05/03/1990WO1990004411A1 Immunogenically active fractions of borrelia burgdorferi
05/03/1990WO1990004410A1 A novel family of high affinity, modified antibodies for cancer treatment
05/03/1990WO1990004405A1 Antiviral agent
05/03/1990WO1990001549A3 Gene encoding protein antigens of plasmodium falciparum
05/03/1990WO1990000594A3 Recombinant mycobacterial expression vehicles and uses therefor
05/02/1990EP0366550A1 Nucleotide sequences expressing adenylate cyclase from B.anthracis, proteins having the activity of this adenylate cyclase and biological uses
05/02/1990EP0366549A1 Derivatives of adenyl cyclase and biological use thereof
05/02/1990EP0366239A1 Purification process for recombinant influenza proteins
05/02/1990EP0366238A2 Influenza vaccinal polypeptides
05/02/1990EP0365997A2 A novel family of high affinity, modified antibodies for cancer treatment
05/02/1990EP0365837A2 Intercellular adhesion molecules, and their binding ligands
05/02/1990EP0365818A1 Immunological detection of atrazine and atrazine derivatives
05/02/1990EP0365643A1 Compounds for diagnosis and/or therapy of tumours
05/02/1990CN1041783A Hybrid monoclonal antibodies, their production and use
05/02/1990CN1007780B Immonologically active whey fraction and recovery process
05/01/1990CA1268600A1 Molecules comprising at least one peptidic sequence carrying an epitope characteristic of a protein produced by cells infected with the malaria parasites and compositions comprising the same
05/01/1990CA1268418A1 Substance-conjugated complement component c1q
04/1990
04/25/1990EP0365209A2 Anti-leu 3A amino acid sequence
04/25/1990EP0365087A1 Immunotoxins for the treatment or prophylaxis of auto-immune diseases
04/25/1990EP0364560A1 Diagnostic methods and systems for quantifying apo ai
04/25/1990EP0364509A1 Cellular toxic conjugates
04/25/1990EP0364492A1 Virus proteins having reduced o-linked glycosylation
04/25/1990EP0364481A1 Growth factors
04/25/1990CA2001508A1 Nucleotide sequences expressing the adenyl cyclase of b. anthracis, proteins having the activity of this adenyl cyclase and biological uses
04/25/1990CA2001320A1 Adenyl cyclase derivatives and biological uses of same
04/24/1990US4920213 Method and compositions useful in preventing equine influenza
04/24/1990US4920209 Oral vaccines
04/24/1990US4919930 Synthetic M proteins-streptococci type 5
04/24/1990US4919929 Inoculating with microencapsulated antigen
04/24/1990US4919927 Using ammonium chloride
04/24/1990CA2001373A1 Methods and compositions for diagnosing, monitoring and treating the early stage of osteoarthritis
04/24/1990CA2001360A1 Monoclonal antibody specifically recognizing sulfated glycolipids
04/21/1990CA2000999A1 Immunotoxins for the treatment of prophylaxis of auto-immune diseases
04/19/1990WO1990004076A1 Combination lock for blood identification system
04/19/1990WO1990004036A1 Production of antibodies from transgenic animals
04/19/1990WO1990004030A1 Sequences of nucleotides coding for a protein having an ureasic activity
04/19/1990WO1990004028A1 Recombinant polypeptides of the hemorragic septicemy virus of fish
04/19/1990WO1990004018A1 Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells
04/19/1990WO1990003984A1 Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
04/19/1990WO1990003982A1 Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof
04/19/1990WO1990003981A1 Peptides and polypeptides from the sub-maxilary gland of the rat, corresponding monoclonal and polyclonal antibodies, corresponding hybridomas and applications of said products to the diagnosis, detection or for therapeutical purposes
04/19/1990WO1990003801A1 Vasopermeability-enhancing conjugates
04/19/1990WO1990003799A1 Radiotherapeutic immunoconjugates labeled with iodine-125
04/19/1990DE3832785A1 Process for obtaining P adhesin
04/18/1990EP0364096A2 Gene expression elements and the production of chimeric mouse-human antibodies
04/18/1990EP0363835A1 Use of zinc or iron hydroxide in the adjuvation of antigen solutions, and antigen solutions adjuvated in this manner
04/18/1990EP0363712A2 Hybrid monoclonal antibodies, their production and use
04/18/1990EP0363703A1 Method of producing human-human hybridomas, the production of monoclonal and polyclonal antibodies therefrom, and therapeutic use thereof
04/18/1990EP0363449A1 Method for detecting antibodies specific for rheumatic diseases, in particular chronic polyarthritis, and reagent therefor.
04/18/1990CN1041392A Method for reduction of heterogeneity of monoclonal antibodies
04/17/1990US4918165 Anticollagen antibody and cytotoxin conjugate
04/17/1990US4918164 Tumor immunotherapy using anti-idiotypic antibodies
04/17/1990US4918163 Medical diagnosis; infection treatment
04/17/1990US4918162 Identifiying neural or lung cancer in human patients
04/17/1990US4917998 Reaction product of body fluid with monoclonal antibody
04/17/1990CA1268000A1 .beta.-D-GALACTOSE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE
04/12/1990CA2000570A1 Bilogically pure recombinant polypeptids, nucleid acids coding for these polypeptids, use of these for the immunization against the virus of the viral hemorragic septicemia of thefish
04/12/1990CA2000549A1 Radiotherapeutic immunoconjugates labeled with iodine-125
04/11/1990EP0363110A2 High pH extraction composition and its use to determine a chlamydial, gonococcal or herpes antigen
04/11/1990EP0362910A2 Synthetic peptides immunochemically reactive with HIV-antibodies
04/11/1990EP0362909A2 Synthetic polypeptides immunochemically reactive with HIV-antibodies
1 ... 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 ... 1823